Organ Health Publications
Read Article
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kidney health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
Expanded eligibility for Natera’s Financial Assistance Program
Read Article
-
Signatera Publications
Read Article
-
Prospera - Increased Risk Result Video
Please watch this short video explaining what your results may mean for you.
Watch Video
-
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Lo
. Vlachou, B.A. Johnson 3rd, M. Kates et al, Eur Urol Open Sci (2025)
Read Publication
-
Dr. Ari Rosenberg SINERGY Data Summary
Dr. Ari Rosenberg from the University of Chicago gives a summary on the SINERGY Trial data that he presented during an oral plenary session at MHNCS.
Watch Video
-
Have a question or comment?
Contact Us -
Fetal Focus: The next-generation single-gene NIPT enables actionable intervention
Watch Video
-
Prospera Case Study Video- Dr. Lodhi
Watch Video
-
What ASCO GI 2026 Means for Patients: How MRD Research Is Shaping GI Cancer Care
Read Article
-
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Ando K, Hamabe A, Nakamura Y, et al. Ann Surg. 2026
Read Publication
-
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy
Chakrabarti S, et al. Cancers. 2026
Read Publication
-
Meet Jon, Muscle-Invasive Bladder Cancer (MIBC) Survivor and Signatera Patient
Read Article
-
QAPI Overview- Dr. Rosenheck
Watch Video
-
The PEDAL Study: Prospera dd-cfDNA use in post-rejection monitoring
Watch Video
-
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer A Nonrandomized Clinic
Han, H.S. et al; JAMA Oncology 2025
Read Publication
-
Adjuvant endocrine therapy with cyclindependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/ HER2– breast canc
Spring L. M. et al; npj Breast Cancer 2025
Read Publication
-
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasi
Foldi J; JCO Precision Oncology 2025
Read Publication
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas
Mittendorf E. A. et al; Nature Medicine 2025
Read Publication
-
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Reason E. H. et al; Ann Surg Oncol 2025
Read Publication
-
Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay
Prasath V, et al; JCO Precision Oncology 2025
Read Publication
-
Circulating tumor DNA refines risk stratification of neoadjuvant therapyresistant breast tumors
Magbanua M. J. et al; Nature Communications 2025
Read Publication
-
Loading More...
